Efficacy of a New Nanoemulsion Artificial Tear in Dry Eye Disease Management
Status:
Recruiting
Trial end date:
2024-11-13
Target enrollment:
Participant gender:
Summary
This is a prospective cohort study to compare subjective changes in symptoms using the Ocular
Surface Disease Index (OSDI) questionnaire, following the recommended dosage of the new
nanoemulsion eye drops (Systane Complete)in mild to moderate dry eye patients, and to
investigate objective ocular surface changes using modern clinical instruments during the
study period.